2222
O. Miyata et al.
LETTER
(10) N-Butyl-1-phenylethylamine was also obtained in 11% yield
as a minor product. This product would be formed by
substitution of the methoxy group with an n-butyl group. P.
Beak11 and co-workers reported nucleophilic displacement
of alkoxide by the alkyl group at the nitrogen atom in the
alkoxyamines.
(11) (a) Beak, P.; Basha, A.; Kokko, B.; Loo, D. J. Am. Chem.
Soc. 1986, 108, 6016. (b) Beak, P.; Basu, K. C.; Lee, J. J. J.
Org. Chem. 1999, 64, 5218. (c) Beak, P.; Basha, A.; Kokko,
B. J. Am. Chem. Soc. 1984, 106, 1511. (d) Boche, G.;
Wagner, H.-U. J. Chem. Soc., Chem. Commun. 1984, 1591.
(e) Dembech, P.; Seconi, G.; Ricci, A. Chem. Eur. J. 2000,
6, 1281. (f) Greck, C.; Genêt, J. P. Synlett 1997, 741.
(12) Typical Procedure for Domino Elimination–
Rearrangement–Addition Reaction of 4,N-Dimethoxy-a-
methyl Benzenemethanamine(3b) with n-BuLi (entry 4
in Table 1).
To a stirred solution of 3b (45 mg, 0.25 mmol) in Et2O (1.7
mL) was added n-BuLi (1.6 mol/L in n-hexane; 0.47 mL,
0.75 mmol) under a nitrogen atmosphere at r.t. After being
stirred at the same temperature for 15 min, the reaction
mixture was diluted with H2O at 0 °C and extracted with
CHCl3. The organic phase was dried over MgSO4 and
concentrated under reduced pressure. Purification of the
residue by PTLC (n-hexane–EtOAc, 6: 1) afforded 4c (44
mg, 85%) as a pale yellow oil. IR: nmax = 3393 cm–1. 1H
NMR (200 MHz): d = 6.77 (2 H, br d, J = 9.0 Hz), 6.55 (2 H,
br d, J = 9.0 Hz), 3.74 (3 H, s), 3.36 (1 H, sext, J = 6.0 Hz),
1.60–1.27 (6 H, m), 1.14 (3 H, d, J = 6.0 Hz), 0.90 (3 H, t,
J = 6.0 Hz). 13C NMR (50 MHz): d = 152.2, 144.0, 115.3,
114.9, 55.7, 50.0, 36.6, 28.3, 22.7, 20.5, 14.0. HRMS: m/z
calcd for C13H21NO [M+]: 207.1624; found: 207.1626.
(13) Hattori, K.; Maruoka, K.; Yamamoto, H. Tetrahedron Lett.
1982, 23, 3395.
(14) le Count, D. J. Comprehensive Heterocyclic Chemistry, Vol.
9; Katritzky, A. R.; Rees, C. W.; Scriven, E. F.; Newcome,
G. R., Eds.; Elsevier: Oxford, 1996, Chap. 9.01, 1–43.
(15) Yamamoto8 group has employed O-ethoxycarbonyl-N-
benzyl-N-cycloalkylhydroxylamines as substrates, which
have no hydrogen atom on a nitrogen atom. Substrates of our
newly found reaction need the secondary amino moiety.
Thus reaction pathway of our domino reaction using
organolithium and organomagnesium reagents would be
completely different from Yamamoto’s reaction.8
References and Notes
(1) (a) Wender, P. A. Chem. Rev. 1996, 96, 1. (b) Pellissier, H.
Tetrahedron 2006, 62, 1619.
(2) (a) Molawi, K.; Schulte, T.; Siegenthaler, K. O.; Wetter, C.;
Studer, A. Chem. Eur. J. 2005, 11, 2335. (b) Leroi, C.;
Fenet, B.; Couturier, J.-L.; Guerret, O.; Ciufolini, M. A. Org.
Lett. 2003, 5, 1079.
(3) Yamamoto, G.; Agawa, C.; Ohno, Y.; Minoura, M.; Mazaki,
Y. Bull. Chem. Soc. Jpn. 2003, 76, 1801.
(4) (a) Tufariello, J. J. 1,3-Dipolar Cycloaddition Chemistry,
Vol. 2; Padwa, A., Ed.; Wiley: New York, 1984, Chap. 9,
83–168. (b) Momiyama, N.; Yamamoto, H. J. Am. Chem.
Soc. 2005, 127, 1080. (c) Young, I. S.; Kerr, M. K. Angew.
Chem. Int. Ed. 2003, 42, 3023.
(5) Miyabe, H.; Ueda, M.; Naito, T. Synlett 2004, 1140.
(6) (a) Miyata, O.; Koizumi, T.; Asai, H.; Iba, R.; Naito, T.
Tetrahedron 2004, 60, 3893. (b) Kiguchi, T.; Tajiri, K.;
Ninomiya, I.; Naito, T. Tetrahedron 2000, 56, 5819.
(c) Booth, S. E.; Jenkins, P. R.; Swain, C. J. J. Chem. Soc.,
Chem. Commun. 1993, 147.
(7) Oximes and oxime ethers are known to undergo domino
reduction–rearrangement via an intermediate of the
corresponding hydroxyl- and alkoxyamines. See:
(a) Sasatani, S.; Miyazaki, T.; Maruoka, K.; Yamamoto, H.
Tetrahedron Lett. 1983, 24, 4711. (b) Cho, H.; Murakami,
K.; Nakanishi, H.; Isoshima, H.; Hayakawa, K.; Uchida, I.
Heterocycles 1998, 48, 919.
(8) Fujiwara, J.; Sano, H.; Maruoka, K.; Yamamoto, H.
Tetrahedron Lett. 1984, 25, 2367.
(9) (a) Danysz, W.; Parsons, C. G. Parmacol. Rev. 1998, 50,
597. (b) Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.
F. Pharmacol. Rev. 1999, 51, 7. (c) Hino, K.; Nagai, Y.;
Uno, H. Chem. Pharm. Bull. 1988, 36, 2386. (d) Aramaki,
Y.; Seto, M.; Okawa, T.; Kansaki, N.; Shiraishi, M. Chem.
Pharm. Bull. 2004, 52, 254. (e) Wallace, O. B.; Lauwers, K.
S.; Jone, S. A.; Dodge, J. A. Bioorg. Med. Chem. Lett. 2003,
13, 1907.
Synlett 2006, No. 14, 2219–2222 © Thieme Stuttgart · New York